Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
Seattle’s Theraclone Strikes $18M Deal to Make Flu-Fighting Antibodies with Japanese Company
|
Luke Timmerman |
10/05/09 |
Seattle
|
|
Vaccine Exec Named SBRI Chair
|
Luke Timmerman |
10/01/09 |
Seattle
|
|
AVI Settles In, ZymoGenetics MS Drug Fails, Dendreon’s FDA Filing Set for Mid-November & More Seattle-Area Life Sciences News
|
Luke Timmerman |
10/01/09 |
Seattle
|
|
The Quest for an HIV Vaccine
|
Lawrence Corey |
09/29/09 |
Seattle
|
|
Five Big Questions For Dendreon’s Analyst Day
|
Luke Timmerman |
09/24/09 |
Seattle
|
|
Gov. Gregoire “Committed” to Biotech Fund While Juggling DC Health Reform, Economy
|
Luke Timmerman |
09/22/09 |
Seattle
|
|
Why Aren’t There Good Drugs for Autism? Ex-MDRNA Exec Takes a Shot at Pharma’s Neglected Disease
|
Luke Timmerman |
09/14/09 |
Seattle
|
|
Finding HIV’s Weak Spot, Scientists at Seattle’s Theraclone and San Diego’s Scripps See Opening for New Vaccine
|
Luke Timmerman |
09/03/09 |
National
|
|
MabVax Raising $4 Million
|
Bruce V. Bigelow |
09/02/09 |
San Diego
|
|
IDRI Licenses Vaccine Microneedles
|
Luke Timmerman |
08/31/09 |
Seattle
|
|
Genocea, Attracting Merck and Wyeth Vaccine Gurus, Pushes New Immunizations to Clinic
|
Luke Timmerman |
08/26/09 |
Boston
|
|
Inovio, Fueled By Swine Flu Fear, Comes Back From Brink With ‘Universal’ Vaccines
|
Luke Timmerman |
08/25/09 |
San Diego
|
|
Cell Therapeutics Nabs $30M, Rick Klausner on Vaccines, Targeted Growth Tinkers With Algae Genes, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
08/20/09 |
Seattle
|
|
VC Rick Klausner on the Future of Vaccines, and Why Dendreon is Only Scratching the Surface
|
Luke Timmerman |
08/19/09 |
Seattle
|
|
Why Big Pharma Wants To Be Like Big Biotech
|
Stewart Lyman |
08/19/09 |
National
|
|
PATH Wins $1.5M Hilton Prize, World’s Biggest Award for Humanitarian Work
|
Luke Timmerman |
08/18/09 |
Seattle
|
|
PATH Scientists Discover Cheap, Easy Way to Protect Vaccines from Hot and Cold
|
Luke Timmerman |
08/04/09 |
Seattle
|
|
Vical on Fast Pace With Animal Tests of Prototype Swine Flu Vaccine
|
Denise Gellene |
06/30/09 |
San Diego
|
|
Sanofi CEO Bets Outside U.S., Gears Up for Flu Pandemic, and Seeks To Learn From Biotech
|
Luke Timmerman |
06/19/09 |
Seattle
|
|
HIV’s “Tireless Warrior,” Anthony Fauci, Calls for Transformation of TB Research
|
Luke Timmerman |
06/18/09 |
Seattle
|
|
Sanofi-Aventis Donates 100 Million Flu Vaccine Doses to WHO at Seattle Summit
|
Luke Timmerman |
06/17/09 |
Seattle
|
|
Seattle’s Pacific Health Summit, the “Davos” of Global Health, Zeroes in on Tuberculosis
|
Luke Timmerman |
06/16/09 |
Seattle
|
|
IDRI Offers Flu Vaccine Boosters
|
Luke Timmerman |
06/11/09 |
Seattle
|
|
Pulmatrix, With One Drug for Multiple Bugs, Aims to Fundamentally Change Flu Treatment
|
Luke Timmerman |
06/09/09 |
Boston
|
|
Inovio and VGX Pharma Merge
|
Bruce V. Bigelow |
06/02/09 |
San Diego
|
|
Sen. Maria Cantwell and Nathan Myhrvold Talk Statewide Innovation at Intellectual Ventures Lab Ceremony
|
Gregory T. Huang |
05/26/09 |
Seattle
|
|
Dendreon Drug Works, But Can It Manufacture Enough to Meet Demand?
|
Luke Timmerman |
05/20/09 |
Seattle
|
|
Targeted Genetics, Mainstay of Gene Therapy, Faces Likely Shutdown
|
Luke Timmerman |
05/07/09 |
Seattle
|
|
Vical Within Days of Prototype H1N1 Vaccine
|
Juha-Pekka Tikka |
05/07/09 |
San Diego
|
|
Dendreon Plans to Raise Cash for Manufacturing, Marketing
|
Luke Timmerman |
05/06/09 |
Seattle
|
|
Page 1 of
3 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
